Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,337 warrant series at 1,058 companies. 779 in the money, 58 expiring in the next 30 days, 39 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Form B Warrants (December 2024 registered direct) | $0.1887 | $6.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Freedom Underwriter Warrants (June 2023) | $0.1887 | $6.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| March 2025 Warrants (registered direct) | $0.1887 | $6.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Maxim Warrants (June 2026 public offering) | $0.1887 | $6.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| October 2025 Closing Warrants (underwritten offering) | $0.1887 | $6.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| October 2025 Option Warrants (over-allotment) | $0.1887 | $6.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Over-Allotment Underwriter Warrants (November 2025, Newbridge) | $0.1887 | $6.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Placement Agent Warrants (August 2024, H.C. Wainwright designees) | $0.1887 | $6.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| September 2025 Warrants (private placement) | $0.1887 | $6.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series A Warrants (August 2024 registered direct) | $0.1887 | $6.8M | 10-K, Mar 31, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series B Warrants (August 2024 registered direct) | $0.1887 | $6.8M | 10-K, Mar 31, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Warrants at $61.00 (series not identified) | $0.1887 | $6.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Warrants at $79.00 (series not identified) | $0.1887 | $6.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Warrants at $98.00 (series not identified) | $0.1887 | $6.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| August 14, 2024 fund-raising warrants (remaining after October 9, 2025 cashless exercise) | $1.62 | $6.8M | 20-F, Jun 30, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Series A Warrants (June 30, 2026 private placement) | $1.62 | $6.8M | 20-F, Jun 30, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Series B Warrants (June 30, 2026 private placement) | $1.62 | $6.8M | 20-F, Jun 30, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Institutional Investor Warrants — April 5, 2023 tranche | $3.50 | $6.7M | 424B5, Dec 10, 2025Dilution tabAs of Oct 5, 2026 | ||||||||
| Institutional Investor Warrants — December 21, 2021 tranche | $3.50 | $6.7M | 424B5, Dec 10, 2025Dilution tabAs of Oct 5, 2026 | ||||||||
| Institutional Investor Warrants — July 26, 2022 tranche | $3.50 | $6.7M | 424B5, Dec 10, 2025Dilution tabAs of Oct 5, 2026 | ||||||||
| June 2025 Warrants (CHF 0.06) | $3.50 | $6.7M | 424B5, Dec 10, 2025Dilution tabAs of Oct 5, 2026 | ||||||||
| Maxim Group LLC warrants (Parent Warrants) | $0.9950 | $6.7M | 6-K EX-10.1, Aug 24, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Series A Warrants (March 2025 unit offering) | $1.07 | $6.6M | 20-F, Jan 23, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| April 2024 common warrants (grant date April 22, 2024, $6.40) | $0.2805 | $6.6M | 10-K, Mar 31, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| May 2023 common warrants (grant date May 09, 2023, $24.00) | $0.2805 | $6.6M | 10-K, Mar 31, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| September 2025 public offering common warrants (grant date September 29, 2025, $1.35) | $0.2805 | $6.6M | 10-K, Mar 31, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| September 25, 2025 warrants ($1.35) | $0.2805 | $6.6M | 10-K, Mar 31, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Legacy common stock warrants (pre-2025, residual) | $0.3273 | $6.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| New Warrants (May 2026 warrant inducement) | $0.3273 | $6.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Placement Agent Warrants (May 2026 warrant inducement, H.C. Wainwright designees) | $0.3273 | $6.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Placement Agent Warrants (September 2026 Private Placement, H.C. Wainwright designees) | $0.3273 | $6.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series A Warrants (March 2026 Private Placement) | $0.3273 | $6.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series B Warrants (March 2026 Private Placement) | $0.3273 | $6.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series C Warrants (September 2026 Private Placement) | $0.3273 | $6.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series D Warrants (September 2026 Private Placement) | $0.3273 | $6.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Warrant Dividend Warrants ($18.48, expiring February 3, 2031) | $0.3273 | $6.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| DITC acquisition pre-funded warrants (issued May 17, 2025, $0.00001) | $0.2762 | $6.5M | 20-F EX-4.26, Oct 1, 2026Dilution tabAs of Oct 14, 2026 | ||||||||
| $18.00 warrants (Zimmer warrant, August 2022) | $0.7066 | $6.4M | 10-Q, Aug 13, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| $33.66 warrants (origin not disclosed) | $0.7066 | $6.4M | 10-Q, Aug 13, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| August 2024 PIPE Warrants (director holder) | $0.7066 | $6.4M | 10-Q, Aug 13, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| August 2024 PIPE Warrants (non-director holders) | $0.7066 | $6.4M | 10-Q, Aug 13, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| Closing Date Debt Facility Warrant (Growth Opportunity Funding, LLC) | $0.7066 | $6.4M | 10-Q, Aug 13, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| December 2025 Placement Agent Warrant (Maxim Group LLC) | $0.4531 | $6.4M | 424B3, Dec 30, 2025Dilution tabAs of Nov 4, 2026 | ||||||||
| December 2025 Pre-Funded Warrants | $0.4531 | $6.4M | 10-Q, Nov 4, 2026Dilution tabAs of Nov 4, 2026 | ||||||||
| December 2025 Warrants (investor common warrants) | $0.4531 | $6.4M | 424B3, Dec 30, 2025Dilution tabAs of Nov 4, 2026 | ||||||||
| January 2026 Pre-Funded Warrants | $0.4531 | $6.4M | 10-Q, Nov 4, 2026Dilution tabAs of Nov 4, 2026 | ||||||||
| January 2026 Warrants | $0.4531 | $6.4M | 10-Q, Nov 4, 2026Dilution tabAs of Nov 4, 2026 | ||||||||
| March 2024 Pre-Funded Warrants | $0.4531 | $6.4M | 10-Q, Nov 4, 2026Dilution tabAs of Nov 4, 2026 | ||||||||
| March 2024 Tranche A Warrants | $0.4531 | $6.4M | 10-Q, Nov 4, 2026Dilution tabAs of Nov 4, 2026 | ||||||||
| March 2024 Tranche B Warrants | $0.4531 | $6.4M | 10-Q, Nov 4, 2026Dilution tabAs of Nov 4, 2026 |
VNRXVolitionRX Ltd$0.1887Last price
Form B Warrants (December 2024 registered direct)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
VNRXVolitionRX Ltd$0.1887Last price
Freedom Underwriter Warrants (June 2023)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
VNRXVolitionRX Ltd$0.1887Last price
March 2025 Warrants (registered direct)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
VNRXVolitionRX Ltd$0.1887Last price
Maxim Warrants (June 2026 public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
VNRXVolitionRX Ltd$0.1887Last price
October 2025 Closing Warrants (underwritten offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
VNRXVolitionRX Ltd$0.1887Last price
October 2025 Option Warrants (over-allotment)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
VNRXVolitionRX Ltd$0.1887Last price
Over-Allotment Underwriter Warrants (November 2025, Newbridge)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
VNRXVolitionRX Ltd$0.1887Last price
Placement Agent Warrants (August 2024, H.C. Wainwright designees)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
VNRXVolitionRX Ltd$0.1887Last price
September 2025 Warrants (private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
VNRXVolitionRX Ltd$0.1887Last price
Series A Warrants (August 2024 registered direct)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
VNRXVolitionRX Ltd$0.1887Last price
Series B Warrants (August 2024 registered direct)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
VNRXVolitionRX Ltd$0.1887Last price
Warrants at $61.00 (series not identified)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
VNRXVolitionRX Ltd$0.1887Last price
Warrants at $79.00 (series not identified)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
VNRXVolitionRX Ltd$0.1887Last price
Warrants at $98.00 (series not identified)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
XTLBXTL Biopharmaceuticals Ltd. American Depositary Shares$1.62Last price
August 14, 2024 fund-raising warrants (remaining after October 9, 2025 cashless exercise)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
XTLBXTL Biopharmaceuticals Ltd. American Depositary Shares$1.62Last price
Series A Warrants (June 30, 2026 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
XTLBXTL Biopharmaceuticals Ltd. American Depositary Shares$1.62Last price
Series B Warrants (June 30, 2026 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
ADXNAddex Therapeutics Ltd American Depositary Shares$3.50Last price
Institutional Investor Warrants — April 5, 2023 tranche
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.7M
ADXNAddex Therapeutics Ltd American Depositary Shares$3.50Last price
Institutional Investor Warrants — December 21, 2021 tranche
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.7M
ADXNAddex Therapeutics Ltd American Depositary Shares$3.50Last price
Institutional Investor Warrants — July 26, 2022 tranche
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.7M
ADXNAddex Therapeutics Ltd American Depositary Shares$3.50Last price
June 2025 Warrants (CHF 0.06)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.7M
ORKTOrangekloud Technology Inc. Class A Ordinary Shares$0.9950Last price
Maxim Group LLC warrants (Parent Warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.7M
BONBon Natural Life Limited Class A Ordinary Shares$1.07Last price
Series A Warrants (March 2025 unit offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.6M
SNGXSoligenix, Inc.$0.2805Last price
April 2024 common warrants (grant date April 22, 2024, $6.40)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.6M
SNGXSoligenix, Inc.$0.2805Last price
May 2023 common warrants (grant date May 09, 2023, $24.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.6M
SNGXSoligenix, Inc.$0.2805Last price
September 2025 public offering common warrants (grant date September 29, 2025, $1.35)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.6M
SNGXSoligenix, Inc.$0.2805Last price
September 25, 2025 warrants ($1.35)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.6M
TPSTTempest Therapeutics, Inc.$0.3273Last price
Legacy common stock warrants (pre-2025, residual)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.5M
TPSTTempest Therapeutics, Inc.$0.3273Last price
New Warrants (May 2026 warrant inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.5M
TPSTTempest Therapeutics, Inc.$0.3273Last price
Placement Agent Warrants (May 2026 warrant inducement, H.C. Wainwright designees)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.5M
TPSTTempest Therapeutics, Inc.$0.3273Last price
Placement Agent Warrants (September 2026 Private Placement, H.C. Wainwright designees)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.5M
TPSTTempest Therapeutics, Inc.$0.3273Last price
Series A Warrants (March 2026 Private Placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.5M
TPSTTempest Therapeutics, Inc.$0.3273Last price
Series B Warrants (March 2026 Private Placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.5M
TPSTTempest Therapeutics, Inc.$0.3273Last price
Series C Warrants (September 2026 Private Placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.5M
TPSTTempest Therapeutics, Inc.$0.3273Last price
Series D Warrants (September 2026 Private Placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.5M
TPSTTempest Therapeutics, Inc.$0.3273Last price
Warrant Dividend Warrants ($18.48, expiring February 3, 2031)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.5M
DOGZDogness (International) Corporation Class A Common Stock$0.2762Last price
DITC acquisition pre-funded warrants (issued May 17, 2025, $0.00001)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.5M
NMTCNeuroOne Medical Technologies Corporation$0.7066Last price
$18.00 warrants (Zimmer warrant, August 2022)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.4M
NMTCNeuroOne Medical Technologies Corporation$0.7066Last price
$33.66 warrants (origin not disclosed)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.4M
NMTCNeuroOne Medical Technologies Corporation$0.7066Last price
August 2024 PIPE Warrants (director holder)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.4M
NMTCNeuroOne Medical Technologies Corporation$0.7066Last price
August 2024 PIPE Warrants (non-director holders)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.4M
NMTCNeuroOne Medical Technologies Corporation$0.7066Last price
Closing Date Debt Facility Warrant (Growth Opportunity Funding, LLC)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.4M
APREAprea Therapeutics, Inc.$0.4531Last price
December 2025 Placement Agent Warrant (Maxim Group LLC)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.4M
APREAprea Therapeutics, Inc.$0.4531Last price
December 2025 Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.4M
APREAprea Therapeutics, Inc.$0.4531Last price
December 2025 Warrants (investor common warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.4M
APREAprea Therapeutics, Inc.$0.4531Last price
January 2026 Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.4M
APREAprea Therapeutics, Inc.$0.4531Last price
January 2026 Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.4M
APREAprea Therapeutics, Inc.$0.4531Last price
March 2024 Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.4M
APREAprea Therapeutics, Inc.$0.4531Last price
March 2024 Tranche A Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.4M
APREAprea Therapeutics, Inc.$0.4531Last price
March 2024 Tranche B Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.4M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,074 dilution snapshots. 4,882 of 5,337 series state an exercise price and 3,371 an expiry date. 219 record when exercise begins; that count grows as companies are re-extracted. 625 series are left off because their figures could not be restated for a stock split. 19 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.